John Chan, MD
Clinical Professor
Ob/Gyn, Reproductive Sciences
School of Medicine

John K. Chan, MD, is the Director of Gynecologic Oncology and a specialist in the surgical and medical treatment of ovarian and other complex pelvic cancers at the UCSF Helen Diller Family Comprehensive Cancer Center. Dr. Chan oversees the Division’s activities and development in patient care, research and education.

Show full bio (80 words) Hide full bio

His research focuses on developing new therapies for gynecologic cancers, including genomic therapy and targeted biologic therapies, as well as investigating the role of tumor-initiating cells in ovarian cancer. He is involved in population-based studies examining treatment and health outcome of ovarian and uterine cancer patients. Dr. Chan has also recently been appointed the principal investigator one of the largest advanced ovarian cancer clinical trials in the world, which is currently under development at the National Cancer Institute.

Grants and Projects

Show all (1) Hide

• Prophylactic oophorectomy: practice patterns &outcomes, NIH, 2008-2010

Publications (3)

Top publication keywords:
Multivariate AnalysisNeoplasms, Glandular and EpithelialAged, 80 and overLymph Node ExcisionOvarian NeoplasmsNeoplasm StagingSarcoma, Endometrial StromalKaplan-Meier EstimateEndometrial NeoplasmsPrognosisEarly DiagnosisLymph NodesSurvival AnalysisSEER ProgramAge Factors

• Endometrial stromal sarcoma: a population-based analysis.
  British journal of cancer 2008 Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS
• The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?
  British journal of cancer 2008 Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, Kapp D, Osann K
• The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.
  British journal of cancer 2007 Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Kapp DS